| Followers | 9 |
| Posts | 3233 |
| Boards Moderated | 0 |
| Alias Born | 04/21/2025 |
Monday, August 25, 2025 9:49:12 AM
Divided up? Among whom?
LP is busy with Toucan, Advent and reportedly other boards she sits on and Innes is not qualified.
It's likely that Les was the backbone of legal matters, B to B negotiations and all the financing deals. There are about 22 total employees, most of which are likely admin and scientist types.
This company has been run like family business for so long, gonna be real hard to let in an outsider who may not like what they see behind the curtain.
Maybe they will bring in someone from Advent, already familiar with the family business? NWBO doesn't seem to have a deep bench WRT replacing Les.
Just my humble opinions...
La cosa nostra
LP is busy with Toucan, Advent and reportedly other boards she sits on and Innes is not qualified.
It's likely that Les was the backbone of legal matters, B to B negotiations and all the financing deals. There are about 22 total employees, most of which are likely admin and scientist types.
This company has been run like family business for so long, gonna be real hard to let in an outsider who may not like what they see behind the curtain.
Maybe they will bring in someone from Advent, already familiar with the family business? NWBO doesn't seem to have a deep bench WRT replacing Les.
Just my humble opinions...
La cosa nostra
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
